HY-100027A-10mg
|
MedChemexpress LLC
|
Ro 41-1049 (hydrochloride) [CAS 127917-66-2]
|
|
Neuroscience-Neuromodulation
|
|
HY-100027A-100mg
|
MedChemexpress LLC
|
Ro 41-1049 (hydrochloride) [CAS 127917-66-2]
|
|
Neuroscience-Neuromodulation
|
|
HY-100027A-5mg
|
MedChemexpress LLC
|
Ro 41-1049 (hydrochloride) [CAS 127917-66-2]
|
|
Neuroscience-Neuromodulation
|
|
HY-100027A-50mg
|
MedChemexpress LLC
|
Ro 41-1049 (hydrochloride) [CAS 127917-66-2]
|
|
Neuroscience-Neuromodulation
|
|
HY-100166-10mg
|
MedChemexpress LLC
|
AP521 [CAS 151227-08-6]
|
|
Neuroscience-Neuromodulation
|
|
HY-100166-100mg
|
MedChemexpress LLC
|
AP521 [CAS 151227-08-6]
|
|
Neuroscience-Neuromodulation
|
|
HY-100166-25mg
|
MedChemexpress LLC
|
AP521 [CAS 151227-08-6]
|
|
Neuroscience-Neuromodulation
|
|
HY-100166-5mg
|
MedChemexpress LLC
|
AP521 [CAS 151227-08-6]
|
|
Neuroscience-Neuromodulation
|
|
HY-100166-50mg
|
MedChemexpress LLC
|
AP521 [CAS 151227-08-6]
|
|
Neuroscience-Neuromodulation
|
|
HY-100234-10mg
|
MedChemexpress LLC
|
DREADD agonist 21 [CAS 56296-18-5]
|
|
Neuroscience-Neuromodulation
|
|
HY-100234-100mg
|
MedChemexpress LLC
|
DREADD agonist 21 [CAS 56296-18-5]
|
|
Neuroscience-Neuromodulation
|
|
HY-100234-2mg
|
MedChemexpress LLC
|
DREADD agonist 21 [CAS 56296-18-5]
|
|
Neuroscience-Neuromodulation
|
|
HY-100234-25mg
|
MedChemexpress LLC
|
DREADD agonist 21 [CAS 56296-18-5]
|
|
Neuroscience-Neuromodulation
|
|
HY-100234-5mg
|
MedChemexpress LLC
|
DREADD agonist 21 [CAS 56296-18-5]
|
|
Neuroscience-Neuromodulation
|
|
HY-100234-50mg
|
MedChemexpress LLC
|
DREADD agonist 21 [CAS 56296-18-5]
|
|
Neuroscience-Neuromodulation
|
|
HY-100234A-10mg
|
MedChemexpress LLC
|
DREADD agonist 21 (dihydrochloride) [CAS 2250025-92-2]
|
|
Neuroscience-Neuromodulation
|
|
HY-100234A-100mg
|
MedChemexpress LLC
|
DREADD agonist 21 (dihydrochloride) [CAS 2250025-92-2]
|
|
Neuroscience-Neuromodulation
|
|
HY-100234A-25mg
|
MedChemexpress LLC
|
DREADD agonist 21 (dihydrochloride) [CAS 2250025-92-2]
|
|
Neuroscience-Neuromodulation
|
|
HY-100234A-5mg
|
MedChemexpress LLC
|
DREADD agonist 21 (dihydrochloride) [CAS 2250025-92-2]
|
|
Neuroscience-Neuromodulation
|
|
HY-100234A-50mg
|
MedChemexpress LLC
|
DREADD agonist 21 (dihydrochloride) [CAS 2250025-92-2]
|
|
Neuroscience-Neuromodulation
|
|
HY-100244-1mg
|
MedChemexpress LLC
|
NS1652 [CAS 1566-81-0]
|
|
Neuroscience-Neuromodulation
|
|
HY-100244-10mg
|
MedChemexpress LLC
|
NS1652 [CAS 1566-81-0]
|
|
Neuroscience-Neuromodulation
|
|
HY-100244-25mg
|
MedChemexpress LLC
|
NS1652 [CAS 1566-81-0]
|
|
Neuroscience-Neuromodulation
|
|
HY-100244-5mg
|
MedChemexpress LLC
|
NS1652 [CAS 1566-81-0]
|
|
Neuroscience-Neuromodulation
|
|
HY-100386-10mg
|
MedChemexpress LLC
|
Ticlopidine [CAS 55142-85-3]
|
|
Neuroscience-Neuromodulation
|
|